C.M.I Dr. Popa Andreea
- Address
- lock Available on a paid plan
C.M.I Dr. Popa Andreea - Addiction Medicine Research
C.M.I Dr. Popa Andreea is a clinical research center specializing in the evaluation of novel therapeutic interventions for substance use disorders. The center demonstrates expertise in conducting controlled clinical trials that assess pharmacological treatments designed to modify addictive behaviors and improve patient outcomes.
- Alcohol use disorder (AUD) treatment interventions
- Novel pharmacological approaches for addiction management
- Behavioral outcome assessments in substance abuse disorders
The center focuses on rigorous evaluation of innovative therapeutic agents such as sunobinop, measuring their efficacy in reducing heavy drinking days and other clinically relevant endpoints. Through controlled study designs, the facility contributes to advancing evidence-based treatment options for individuals struggling with alcohol use disorder and related conditions.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in C.M.I Dr. Popa Andreea
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Sunobinop Tosilate on Alcohol Consumption and Craving in Patients with Moderate to Severe Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled Study | Knoa Pharma LLC | Phase II | Not Recruiting | May 2025 | May 2026 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.